Tag Archive for: lipid nanoparticle delivery

A U.S. appeals court handed Moderna Inc. a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp. patent related to the companies’ legal fight over Moderna’s blockbuster COVID-19 vaccines.

On a collaboration streak, Merck is pouring a potential $3.5 billion into a partnership with circular RNA company Orna Therapeutics to develop and commercialize multiple oncology and infectious disease programs.